These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35369701)

  • 1. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry.
    Price MJ; Valderrábano M; Zimmerman S; Friedman DJ; Kar S; Curtis JP; Masoudi FA; Freeman JV
    Circ Cardiovasc Interv; 2022 May; 15(5):e011718. PubMed ID: 35369701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedures in the United States.
    Munir MB; Khan MZ; Darden D; Pasupula DK; Balla S; Han FT; Reeves R; Hsu JC
    Heart Rhythm; 2021 Sep; 18(9):1508-1515. PubMed ID: 34020049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device-Sizing and Associated Complications With Left Atrial Appendage Occlusion: Findings From the NCDR LAAO Registry.
    Sandhu A; Varosy PD; Du C; Aleong RG; Tumolo AZ; West JJ; Tzou WS; Curtis JP; Freeman JV; Friedman DJ; Hess PL
    Circ Cardiovasc Interv; 2022 Dec; 15(12):e012183. PubMed ID: 36472194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
    Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
    Darden D; Duong T; Du C; Munir MB; Han FT; Reeves R; Saw J; Zeitler EP; Al-Khatib SM; Russo AM; Minges KE; Curtis JP; Freeman JV; Hsu JC
    JAMA Cardiol; 2021 Nov; 6(11):1275-1284. PubMed ID: 34379072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCDR Left Atrial Appendage Occlusion Registry.
    Freeman JV; Varosy P; Price MJ; Slotwiner D; Kusumoto FM; Rammohan C; Kavinsky CJ; Turi ZG; Akar J; Koutras C; Curtis JP; Masoudi FA
    J Am Coll Cardiol; 2020 Apr; 75(13):1503-1518. PubMed ID: 32238316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States.
    Price MJ; Slotwiner D; Du C; Freeman JV; Turi Z; Rammohan C; Kusumoto FM; Kavinsky C; Akar J; Varosy PD; Koutras C; Curtis JP; Masoudi FA
    JACC Cardiovasc Interv; 2022 Apr; 15(7):741-750. PubMed ID: 35393108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry.
    Daimee UA; Wang Y; Masoudi FA; Varosy PD; Friedman DJ; Du C; Koutras C; Reddy VY; Saw J; Price MJ; Kusumoto FM; Curtis JP; Freeman JV
    Circ Cardiovasc Qual Outcomes; 2022 Aug; 15(8):e008418. PubMed ID: 35959677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry.
    Kapadia SR; Yeh RW; Price MJ; Piccini JP; Nair DG; Bansal A; Hsu JC; Freeman JV; Christen T; Allocco DJ; Gibson DN
    Circ Cardiovasc Interv; 2024 Sep; 17(9):e013750. PubMed ID: 39056187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis.
    Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ
    Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural Outcomes Associated With Use of a Left Atrial Appendage Occlusion Device in China.
    Su F; Gao C; Liu J; Ning Z; He B; Liu Y; Xu Y; Yang B; Li Y; Zhang J; Zhao X; Zhang Y; Hu H; Du X; Xie R; Zhou L; Zeng J; Ruan Z; Liu H; Guo J; Wang R; Garg S; Soliman O; Holmes DR; Serruys PW; Tao L
    JAMA Netw Open; 2022 May; 5(5):e2214594. PubMed ID: 35639378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
    Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
    Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk.
    Messele LF; Khan MZ; Darden D; Agarwal S; Krishan S; Pasupula DK; Ul Abideen Asad Z; Balla S; Singh GD; Srivatsa UN; Munir MB
    Europace; 2023 Apr; 25(4):1415-1422. PubMed ID: 36881781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
    Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
    JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
    Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation.
    Kapadia SR; Krishnaswamy A; Whisenant B; Potluri S; Iyer V; Aragon J; Gideon P; Strote J; Leonardi R; Agarwal H; Larrain G; Sanchez C; Panaich SS; Harvey J; Vahl T; Menon V; Wolski K; Wang Q; Leon MB
    Circulation; 2024 Mar; 149(10):734-743. PubMed ID: 37874908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of ablation for atrial fibrillation in combination with left atrial appendage occlusion in octogenarians.
    Zhang PP; Zhao Y; Sun J; Wang QS; Li W; Zhang R; Chen M; Mo BF; Yu Y; Feng XF; Liu B; Yu YC; Lu QF; Li YG
    Clin Cardiol; 2023 Oct; 46(10):1202-1209. PubMed ID: 37522390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of pericardial effusion after left atrial appendage closure: The impact of underlying heart rhythm-Data from the EWOLUTION study.
    Schmidt B; Betts TR; Sievert H; Bergmann MW; Kische S; Pokushalov E; Schmitz T; Meincke F; Mazzone P; Stein KM; Ince H; Boersma LVA
    J Cardiovasc Electrophysiol; 2018 Jul; 29(7):973-978. PubMed ID: 29722469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericardial Effusion After Left Atrial Appendage Closure: Timing, Predictors, and Clinical Impact.
    Galea R; Bini T; Krsnik JP; Touray M; Temperli FG; Kassar M; Papadis A; Gloeckler S; Brugger N; Madhkour R; Seiffge DJ; Roten L; Siontis GCM; Heg D; Windecker S; Räber L
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1295-1307. PubMed ID: 38795087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.